Exosome Diagnostics Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test Bio-Techne's CEO said the coverage decision will expand access to its EPI test and enable additional men to better decide whether to proceed with a prostate biopsy. Qiagen, Exosome Dx Building Urine-Based Digital PCR Workflow for FGFR Mutations in Bladder Cancer Premium The firms will present a clinical comparison study using the workflow to detect FGFR mutations in 50 urothelial cancer patients later this year. In Brief This Week: Guardant Health, Illumina, Twist Bioscience, Hologic, InCellDx, More News items for the week of June 8, 2020. Bio-Techne Bets Clinical Utility Study Data Will Sway Payors to Cover Prostate Cancer Risk Test Premium The Minneapolis-based firm believes the assay can successfully serve as a clinical indicator for patients at risk of developing high-grade prostate cancer (HGPC), thereby improving prostate cancer management. Bio-Techne Receives Medicare Coverage for Prostate Cancer Test The decision, which enables Medicare reimbursement, is effective for tests administered on or after Dec. 1. Jun 13, 2019 Bio-Techne Gets New York State Approval for Prostate Cancer Test Dec 12, 2018 Exosome Diagnostics Suing Former Employee for IP Theft Aug 7, 2018 Bio-Techne Fiscal Q4 Revenues Climb 15 Percent Aug 1, 2018 Bio-Techne Completes Exosome Dx Acquisition Jun 25, 2018 Bio-Techne to Acquire Exosome Dx for up to $575M Jun 15, 2018 In Brief This Week: Genedrive, Exosome Dx, Luminex, More Apr 2, 2018 Poised to Join Complex Market, Exosome Dx Publishes Validation Data for EGFR T790M Assay Premium Mar 14, 2018 Exosome Diagnostics, Intezyne to Develop Exosomal RNA Assay for Novel CRP Inhibitor Feb 6, 2018 Exosome Diagnostics Taking Aim at Protein Analysis With Release of Shahky System Premium Jan 8, 2018 CareFirst BCBS to Cover Exosome Dx Prostate Cancer Test Sep 26, 2017 Acoustics-Based Method for Isolating Exosomes Could Accelerate Liquid Biopsies Premium Sep 19, 2017 Exosome Diagnostics Launches Evidence Development Study for Prostate Cancer Test Aug 24, 2017 CareFirst BCBS, Exosome Dx Partner on Evidence Development Studies Aug 4, 2017 In Brief This Week: Thermo Fisher, Grifols, MDxHealth, Exosome Diagnostics, and More Jul 24, 2017 Exosome Diagnostics Completes $30 Million Series C Financing May 30, 2017 Lonza's New Investments in Exosome Technologies Reflect Growing Industry Interest Premium May 16, 2017 Lonza Acquires HansaBioMed, Invests in Exosomics Feb 6, 2017 Exosome Diagnostics Announces Agreement With Merck KGaA Jan 20, 2017 In Brief This Week: Ambry Genetics, DNAstack, Protea Biosciences, and More Dec 13, 2016 Exosome Dx Launches Protein Analysis Instrument, Retains Dx Business Focus Premium Load More Breaking News Analysis Finds Sibling Cascade Testing Could Be Cost Effective in Pediatric Cancer Armonica Technologies Closes $2M Series B Financing Round Top Five Articles on GenomeWeb Last Week: SARS-CoV-2 PCR Tests; California Cancer Testing Law; More In Brief This Week: The Jackson Laboratory, CareDx, Merck Global Health Innovation Fund, and More People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More New Products Posted to GenomeWeb: NanoString, Sophia Genetics, EliTech, Lybe Scientific, More The Scan J&J Booster Support A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times. To Keep the Cases Moving The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases. NAS Expels Archaeologist Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences. PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.